Scott E. Warder

1.1k total citations
27 papers, 590 citations indexed

About

Scott E. Warder is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Scott E. Warder has authored 27 papers receiving a total of 590 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Scott E. Warder's work include Chemical Synthesis and Analysis (8 papers), Protein Degradation and Inhibitors (7 papers) and Ubiquitin and proteasome pathways (5 papers). Scott E. Warder is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Protein Degradation and Inhibitors (7 papers) and Ubiquitin and proteasome pathways (5 papers). Scott E. Warder collaborates with scholars based in United States, Finland and United Kingdom. Scott E. Warder's co-authors include Francis Castellino, Mary Prorok, Tamás Blandl, Shaun M. McLoughlin, Anil Vasudevan, Paul L. Richardson, Feng Ni, Michael J. Liguori, Kenneth M. Comess and James J. Lynch and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Scott E. Warder

25 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott E. Warder United States 16 416 111 86 75 56 27 590
April Case United States 14 442 1.1× 35 0.3× 134 1.6× 86 1.1× 35 0.6× 18 902
Philippe Cronet Germany 13 654 1.6× 115 1.0× 51 0.6× 25 0.3× 28 0.5× 15 787
Gareth Wayne United Kingdom 12 291 0.7× 48 0.4× 93 1.1× 70 0.9× 28 0.5× 13 605
George H. Addona United States 12 372 0.9× 130 1.2× 43 0.5× 30 0.4× 33 0.6× 21 578
Mark R. Southern United States 15 580 1.4× 47 0.4× 60 0.7× 37 0.5× 115 2.1× 19 776
Hye-Ja Oh United States 13 471 1.1× 85 0.8× 176 2.0× 118 1.6× 21 0.4× 19 662
Jun Xian United States 12 460 1.1× 52 0.5× 68 0.8× 87 1.2× 24 0.4× 18 662
Serdar Kurtkaya United States 8 434 1.0× 62 0.6× 129 1.5× 158 2.1× 20 0.4× 8 756
Kenji Ohgane Japan 13 347 0.8× 62 0.6× 104 1.2× 98 1.3× 14 0.3× 38 559
János Seprődi Hungary 16 378 0.9× 47 0.4× 219 2.5× 80 1.1× 40 0.7× 45 705

Countries citing papers authored by Scott E. Warder

Since Specialization
Citations

This map shows the geographic impact of Scott E. Warder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Warder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Warder more than expected).

Fields of papers citing papers by Scott E. Warder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Warder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Warder. The network helps show where Scott E. Warder may publish in the future.

Co-authorship network of co-authors of Scott E. Warder

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Warder. A scholar is included among the top collaborators of Scott E. Warder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Warder. Scott E. Warder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Conway, Louis P., Appaso Mahadev Jadhav, Kathy Sarris, et al.. (2025). Proteome-Wide Discovery of Degradable Proteins Using Bifunctional Molecules. ACS Central Science. 11(11). 2240–2256.
2.
Zheng, Yunan, Anamika Singh, Violeta L. Marin, et al.. (2025). In-Cell Approach to Evaluate E3 Ligases for Use in Targeted Protein Degradation. Journal of the American Chemical Society. 147(25). 21560–21574. 2 indexed citations
3.
Ronau, J.A., Aaron Ehlinger, Shigeyo Hyman, et al.. (2025). A paradigm shift: analytical ultracentrifugation as a multi-attribute platform method in targeted protein degradation. European Biophysics Journal. 54(6). 385–402.
4.
Lynch, Thomas L., Violeta L. Marin, Ryan A. McClure, et al.. (2024). Quantitative Measurement of Rate of Targeted Protein Degradation. ACS Chemical Biology. 19(7). 1604–1615. 5 indexed citations
5.
Comess, Kenneth M., Shaun M. McLoughlin, Jon A. Oyer, et al.. (2018). Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners’ Perspective. Journal of Medicinal Chemistry. 61(19). 8504–8535. 49 indexed citations
6.
Tang, Hua, et al.. (2015). Target Identification of Compounds from a Cell Viability Phenotypic Screen Using a Bead/Lysate-Based Affinity Capture Platform. SLAS DISCOVERY. 21(2). 201–211. 12 indexed citations
7.
Carr, Tracy L., Rita Ciurlionis, Ivan Milicic, et al.. (2010). Role of cytochrome P450c17α in dibromoacetic acid-induced testicular toxicity in rats. Archives of Toxicology. 85(5). 513–523. 9 indexed citations
8.
Warder, Scott E., Lora A. Tucker, Evelyn McKeegan, et al.. (2009). Reducing agent-mediated precipitation of high-abundance plasma proteins. Analytical Biochemistry. 387(2). 184–193. 48 indexed citations
9.
Waring, Jeffrey F., Yi Yang, Andrew Adler, et al.. (2007). Gene Expression Analysis in Rats Treated with Experimental Acetyl-Coenzyme A Carboxylase Inhibitors Suggests Interactions with the Peroxisome Proliferator-Activated Receptor α Pathway. Journal of Pharmacology and Experimental Therapeutics. 324(2). 507–516. 17 indexed citations
10.
Klein, Rebecca C., Scott E. Warder, Zygmunt Galdzicki, Francis Castellino, & Mary Prorok. (2001). Kinetic and mechanistic characterization of NMDA receptor antagonism by replacement and truncation variants of the conantokin peptides. Neuropharmacology. 41(7). 801–810. 11 indexed citations
11.
Warder, Scott E., Tamás Blandl, Rebecca C. Klein, Francis Castellino, & Mary Prorok. (2001). Amino acid determinants for NMDA receptor inhibition by conantokin‐T. Journal of Neurochemistry. 77(3). 812–822. 16 indexed citations
12.
Warder, Scott E., et al.. (2000). An internal histidine residue from the bacterial surface protein, PAM, mediates its binding to the kringle‐2 domain of human plasminogen. Journal of Peptide Research. 56(6). 438–445. 22 indexed citations
13.
Blandl, Tamás, Scott E. Warder, Mary Prorok, & Francis Castellino. (2000). Structure–function relationships of the NMDA receptor antagonist peptide, conantokin‐R. FEBS Letters. 470(2). 139–146. 23 indexed citations
14.
Blandl, Tamás, et al.. (1999). Binding of cations to individual gamma‐carboxyglutamate residues of conantokin‐G and conantokin‐T. Journal of Peptide Research. 53(4). 453–464. 13 indexed citations
15.
Blandl, Tamás, Mary Prorok, Scott E. Warder, et al.. (1998). Conformational Changes in Conantokin-G Induced upon Binding of Calcium and Magnesium as Revealed by NMR Structural Analysis. Journal of Biological Chemistry. 273(26). 16248–16258. 34 indexed citations
16.
Warder, Scott E., Mary Prorok, Zhigang Chen, et al.. (1998). The Roles of Individual γ-Carboxyglutamate Residues in the Solution Structure and Cation-dependent Properties of Conantokin-T. Journal of Biological Chemistry. 273(13). 7512–7522. 25 indexed citations
17.
Warder, Scott E., et al.. (1997). The NMR solution structure of the NMDA receptor antagonist, conantokin‐T, in the absence of divalent metal ions. FEBS Letters. 411(1). 19–26. 27 indexed citations
18.
Siddiqui, M. Arshad, et al.. (1997). Synthesis of constrained bicyclic dipeptide mimetics. Tetrahedron Letters. 38(51). 8807–8810. 12 indexed citations
19.
Prorok, Mary, Jieping Geng, Scott E. Warder, & Francis Castellino. (1996). The entire γ‐carboxyglutamic acid‐ and helical stack‐domains of human coagulation factor IX are required for optimal binding to its endothelial cell receptor. International journal of peptide & protein research. 48(3). 281–285. 7 indexed citations
20.
Hoover, Gordon J., et al.. (1993). Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with .omega.-amino acids. Biochemistry. 32(41). 10936–10943. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by April Case Breakdown of academic impact, for papers by Philippe Cronet Breakdown of academic impact, for papers by Gareth Wayne Breakdown of academic impact, for papers by George H. Addona Breakdown of academic impact, for papers by Mark R. Southern Breakdown of academic impact, for papers by Hye-Ja Oh Breakdown of academic impact, for papers by Jun Xian Breakdown of academic impact, for papers by Serdar Kurtkaya Breakdown of academic impact, for papers by Kenji Ohgane Breakdown of academic impact, for papers by János Seprődi
Rankless by CCL
2026